Medicare’s push to improve chronic care faces enrollment issues
While the Chronic Care management program shows promise in reducing costs, uptake in it has been sluggish
While the Chronic Care management program shows promise in reducing costs, uptake in it has been sluggish
Ensign Group’s CEO is on the lookout for more nursing homes as it announced the acquisition of seven operations Wednesday.
The average total compensation for CEOs of the major health insurance companies increased 5.7% to $20.6 million last year, according to regulatory filings.
Ashish Kamat introduces Jeffrey Holzbeierlein, who discusses the recent updates to the American Urological Association’s (AUA) guidelines for managing non-muscle invasive bladder cancer. Published in…
APCCC 2024, metastatic hormone-sensitive prostate cancer (mHSPC), Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography (PSMA-PET), ARCHES trial, enzalutamide, Delta-like ligand 3 (DLL3), LuPSMA.
Nonsense-mediated RNA decay, or NMD, is an evolutionarily conserved molecular mechanism in which potentially defective messenger RNAs, or mRNAs (genetic material that instructs the body…
Emergent BioSolutions said on Wednesday that it would cut about 300 jobs across all areas of the company and shut down several manufacturing facilities as…
Sam Chang and Siamak (Sia) Daneshmand discuss the ABLE-41 trial, focusing on the real-world usage of nadofaragene firadenovec for bladder cancer. Discussing the trial’s design…
A third of nonprofit hospitals received “A” safety grades from the Leapfrog Group, compared with 28% of for-profit and 17% of government-owned facilities.
CVS Health is lowering its guidance for the year after a first-quarter miss on both profit and revenue. | The company posted $1.1 billion in…
APCCC 2024, Radioligand Therapy, Dosing of Radioligand Therapy, Dosing of Radioligand Therapy in Special Situations And/or Toxicity, 177Lu-PSMA, VISION trial, Lu-PSMA therapy, Lu-PSMA I&T, ENZA-p…